RXO SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES RXO INC.
RXO shareholders will receive just $17.25 per share in cash and 0.0856 shares of C.H. Robinson Worldwide common stock for each RXO share, representing an implied total consideration of $30.25 per share in a transaction valued at approximately $5.8 billion; Ademi LLP is investigating the...
Covered in this story
What has happened since
- C.H. Robinson is down 0.0% since this was published, 15 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Rxo Inc
- BMO Capital Markets: $28.6 → $30.3 by Oct 2027 · Market Perform via Investing.com
- JPMorgan: $28.6 → $30 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $28.6 → $30.3 by Oct 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RXO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rxo Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.